The Analysis of Correlation About the Spot Urine Sodium and the Blood Pressure in General Population According to the Income Level

NCT ID: NCT01960608

Last Updated: 2016-03-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

7000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Increasing sodium intake raises blood pressure. And high salt intake could hinder the management of chronic disease. Much previous research has confirmed that dietary habits are affected by economic status. So we compared sodium intake with economic status. We investigated the prevalence, extent and management, and the relevance of sodium intake with income level.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

low sodium group

24\_hours\_urine\_sodium \< 100 mEq/L

24_hours_urine_sodium

Intervention Type OTHER

mid sodium group

24\_hours\_urine\_sodium \>= 100 mEq/L and \< 200 mEq/L

24_hours_urine_sodium

Intervention Type OTHER

high sodium group

24\_hours\_urine\_sodium \>= 200 mEq/L

24_hours_urine_sodium

Intervention Type OTHER

low income group

the income 25% below the quartile

No interventions assigned to this group

low mid income group

the income 25% - 50% below the quartile

No interventions assigned to this group

mid income group

the income 50% - 75% below the quartile

No interventions assigned to this group

high income group

the income 75% over the quartile

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

24_hours_urine_sodium

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all the patient who participated in the national survey

Exclusion Criteria

* no pregnancy
* malignancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Inje University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hoseok Koo

Assisted professior

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Inje University Seoul Paik Hospital

Seoul, Seoul, South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

sodium_income

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dietary Salt Intake and Vascular Function
NCT00590512 COMPLETED EARLY_PHASE1
Clarifying Optimal Sodium Intake Project
NCT02738736 COMPLETED PHASE2